Jody Staggs
About Jody Staggs
SWK Holdings President & CEO
Jody Staggs is the current President and CEO of SWK Holdings, having assumed the role in January 2023. He joined the company as a Senior Analyst in August 2015. He then moved up the ranks, being promoted to Managing Director in January 2020, later becoming President and Interim CEO in September 2022 before taking on his current position. Jody’s leadership plays a critical role in SWK Holdings’ strategic direction and overall operations.
Investment Experience at Annandale Capital and More
Prior to joining SWK Holdings, Jody Staggs served as the Vice President of Investments at Annandale Capital, where he was involved in investment strategies and portfolio management. His career includes being the first employee at Alistair Capital, a Dallas-based hedge fund, and co-founding PBS Capital, where he focused on investment management, pharmaceutical royalties, and healthcare equities. These roles have equipped Jody with extensive experience in the investment sector.
Highland Capital Senior Portfolio Analyst
Jody Staggs worked as a Senior Portfolio Analyst at Highland Capital, concentrating on healthcare multi-strategy investments and public equity groups. During his tenure, he excelled in his performance, ranking first out of a class of eight analysts. This experience has contributed significantly to his expertise in healthcare investment strategies.
Academic Credentials and CFA Designation
Jody Staggs graduated with a B.A. in Finance from the University of Arkansas, where he was a Walton Scholar and made the Dean’s List. His commitment to his education and professional development is further demonstrated by earning the Chartered Financial Analyst designation. These academic credentials have provided a strong foundation for his career in finance and investment.
Published Work on Royalty Financing
Jody Staggs authored a guest column titled 'Why Royalty Financing Is A Smart Funding Alternative For Small Life Science Companies,' which was published on September 27, 2023. In this article, he explored the benefits and strategic importance of royalty financing for small life science companies, showcasing his expertise in innovative financing solutions within the healthcare sector.